Status:
COMPLETED
Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
Lead Sponsor:
University of Florida
Conditions:
Glioblastoma Multiforme
Healthy Volunteers
Eligibility:
All Genders
18-89 years
Brief Summary
The purpose of this study is to determine if tumor cells can be detected in the blood of patients diagnosed with a brain tumor.
Detailed Description
Despite aggressive therapies, Glioblastoma Multiforme (GBM) is rapidly fatal. GBMs are increasingly recognized for occasionally metastasizing through the peripheral blood to distant locations. This re...
Eligibility Criteria
Inclusion
- 18 to 89 years of age
- Weight of at least 110 pounds
- Able to provide informed consent for self
Exclusion
- Patients with active malignant tumors other than GBM
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT01135875
Start Date
October 1 2009
End Date
April 1 2013
Last Update
October 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610